Trials / Completed
CompletedNCT01380132
Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Uppsala University Hospital · Academic / Other
- Sex
- —
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether anorectal application of Nasha Dx is safe and effective for treatment of anal incontinence.
Detailed description
Patients not fully improved after 1:st injection were offered reinjection after 4-6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Anal injection of Nasha Dx | Submucous injection of Nasha Dx 5-10 mm above dentate line |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2009-01-01
- Completion
- 2009-05-01
- First posted
- 2011-06-27
- Last updated
- 2011-06-28
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01380132. Inclusion in this directory is not an endorsement.